Interest in the pathophysiology, etiology, management, and outcomes of patients with
tricuspid regurgitation (TR) has grown in the wake of multiple natural history studies showing …

The Shock Academic Research Consortium is a multi-stakeholder group, including
representatives from the US Food and Drug Administration and other government agencies …

Background A previous analysis in this trial showed that among patients with severe,
symptomatic aortic stenosis who were at low surgical risk, the rate of the composite end …

Background Patients with severe aortic stenosis and a small aortic annulus are at risk for
impaired valvular hemodynamic performance and associated adverse cardiovascular …

Approximately 4% of subjects aged 75 years or more have clinically relevant tricuspid
regurgitation (TR). Primary TR results from anatomical abnormality of the tricuspid valve …

Background In low surgical risk patients with symptomatic severe aortic stenosis, the
PARTNER 3 (Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low …

Aims The aims of the study were to compare clinical outcomes and valve durability after 8
years of follow-up in patients with symptomatic severe aortic valve stenosis at low surgical …

Background Among low-risk patients with severe, symptomatic aortic stenosis who are
eligible for both transcatheter aortic-valve implantation (TAVI) and surgical aortic-valve …

Background Randomized data comparing outcomes of transcatheter aortic valve
replacement (TAVR) with surgery in low–surgical risk patients at time points beyond 2 years …

Background: Although transcatheter aortic valve replacement (TAVR) therapy continues to
grow, there have been concerns about the occurrence of hypoattenuating leaflet thickening …